SCHEMBL29385353

SCHEMBL29385353

C[Si](C)(C)CCOCn1cnc2c(N)ncnc21

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 6/20 0.57
ADORA1 P30542 4/20 0.57
PI4KA P42356 2/20 0.57
PI4K2B Q8TCG2 2/20 0.57
PI4K2A Q9BTU6 2/20 0.57
PI4KB Q9UBF8 2/20 0.57
ENPP1 P22413 2/20 0.57
NT5E P21589 1/20 0.56
ADORA2B P29275 1/20 0.55
NSD3 Q9BZ95 4/20 0.51
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
FGFR1 P11362 1/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
AHCY P23526 1/20 0.50
HPGD P15428 1/20 0.49
NSD2 O96028 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18786971 1.00 ADORA2A (0.57) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL20096689 0.86 ADORA2A (0.66) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL11247503 0.84 ENPP1 (0.60) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL29878068 0.83 ENPP1 (0.40) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL126904 0.83 ENPP1 (0.40) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL357273 0.83 FDPS (0.45) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL20404701 0.83 ENPP1 (0.43) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL355371 0.83 ENPP1 (0.40) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL31340868 0.83 FDPS (0.45) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL2293269 0.83 ADORA2A (0.66) ADORA2AADORA1PI4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116490505-A MNK inhibitors 和博医药有限公司 2023-07-25 CN disclosed
EP-4200296-A1 MNK INHIBITORS Hepagene Therapeutics (HK) Limited (HK) 2023-06-28 EP disclosed
WO-2022038563-A1 MNK INHIBITORS Hepagene Therapeutics (HK) Limited (CN) 2022-02-24 WO disclosed
CN-114026093-A Compositions for treating neurodegenerative and mitochondrial diseases and methods of use thereof 麦托吉宁公司 2022-02-08 CN disclosed